Newsletter | June 26, 2025

06.27.25 -- Winning Management Strategies For Early And Late-Stage Drug Development

SPONSOR

Mark your calendar for BioFuture™ 2025!

BioFuture returns to New York City this October, bringing together pioneers, investors, and decision-makers who are redefining the future of medicine. This year’s summit will focus on the convergence of biopharma, digital medicine, big data, and TechBio. With 600+ attendees, 100+ speakers, and 80+ presenting companies. Learn more and register.

FEATURED ARTICLE

Winning Management Strategies For Early And Late-Stage Drug Development

Modern drug development approaches that integrate functional plans with larger business goals are needed for success in early and late-stage drug development, explains Halloran's Carolina Ahrendt.

INDUSTRY INSIGHTS

2025 Trends In Patient Recruitment: From Disruption To Precision

Explore the four macro trends reshaping the recruitment space in 2025—each grounded in emerging data, technology, and behavior shifts.

Intensifying Upstream Processing: Implications For Media Management

We discuss the benefits of implementing PI before exploring the potential implications on media management and outline the value in conceptual design to assist with the logistics of the media journey.

How MSAT Drives Efficient Tech Transfer

A CDMO’s manufacturing science and technology (MSAT) plays a critical role in optimizing a biomanufacturing process to meet the needs of the modern healthcare landscape.

Driving ROI: The Business Case For A Financial Transformation Solution

Learn how comprehensive financial transformation solutions address budgeting and site payment challenges, drive value across the study lifecycle, and deliver operational and business benefits.

Clinical Trial Payments And Ethics: Your Top Questions Answered

In response to widespread uncertainty around ethical clinical trial payments, this article explores foundational questions surrounding participant compensation.

Nitrosamine Impurities: Are Your Products Compliant?

Potential strategies for vulnerable drug products include shelf-life reduction, investigating nitrite contribution from excipient suppliers, examining formulation processes, and introducing additives.

CONTRIBUTE TO LIFE SCIENCE LEADER

Article Submission Guidelines

Think you have a good idea for an article that Life Science Leader readers would find valuable?  Read these guidelines first before submitting your idea or your article to our editorial director.